PI
MREO

PFG Investments’s Mereo BioPharma MREO Stock Holding History

PFG Investments’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,650
Closed -$6.94K – 1232
2025
Q4 		$6.94K Sell
16,650
-500
-3% -$952 ﹤0.01% 1148
2025
Q3 		$35.3K Sell
17,150
-20,283
-54% -$37.4K ﹤0.01% 1091
2025
Q2 		$101K Hold
37,433
– – 0.01% 974
2025
Q1 		$84.2K Sell
37,433
-2,000
-5% -$5.66K 0.01% 951
2024
Q4 		$138K Buy
39,433
+22,433
+132% +$88.1K 0.01% 935
2024
Q3 		$69.9K Hold
17,000
– – ﹤0.01% 960
2024
Q2 		$61.2K Sell
17,000
-14,200
-46% -$46K ﹤0.01% 888
2024
Q1 		$103K Buy
31,200
+1,200
+4% +$4.06K 0.01% 962
2023
Q4 		$69.3K Hold
30,000
– – 0.01% 470
2023
Q3 		$38.7K Sell
30,000
-1,500
-5% -$1.99K 0.01% 502
2023
Q2 		$41.6K Sell
31,500
-16,000
-34% -$18.6K 0.01% 507
2023
Q1 		$33.6K Buy
+47,500
New +$42.7K 0.01% 484

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

PFG Investments's MREO Position: Q1 2026 in Review

PFG Investments sold out of Mereo BioPharma (MREO) in Q1 2026, closing a stake of 16,650 shares — an estimated $6.94K sold.

PFG Investments first reported a position in MREO in Q1 2023 and held it in 12 quarters. The position peaked at $138K in Q4 2024. 63 funds tracked by Wall St. Rank hold MREO as of Q1 2026.

  • PFG Investments reported no remaining Mereo BioPharma position as of Q1 2026 after selling out during the quarter.
  • PFG Investments sold 16,650 Mereo BioPharma shares in Q1 2026, an estimated $6.94K.
  • PFG Investments first reported a position in Mereo BioPharma in Q1 2023 and held it in 12 quarters.
  • PFG Investments's Mereo BioPharma position peaked at $138K in Q4 2024.
  • 63 funds tracked by Wall St. Rank held Mereo BioPharma as of Q1 2026.

Based on PFG Investments's 13F filing for Q1 2026, filed 27 Apr 2026.